T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alcon
ALC
|
+$2.11B |
| 2 |
Linde
LIN
|
+$1.34B |
| 3 |
American International
AIG
|
+$1.34B |
| 4 |
Marvell Technology
MRVL
|
+$1.28B |
| 5 |
TSS
Total System Services, Inc.
TSS
|
+$1.24B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$2.27B |
| 2 |
Eli Lilly
LLY
|
+$1.64B |
| 3 |
NVIDIA
NVDA
|
+$1.59B |
| 4 |
RHT
Red Hat Inc
RHT
|
+$1.55B |
| 5 |
Booking.com
BKNG
|
+$1.12B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.88% |
| 2 | Healthcare | 16.96% |
| 3 | Financials | 13.79% |
| 4 | Consumer Discretionary | 13.57% |
| 5 | Industrials | 9.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SBT
901
DELISTED
Sterling Bancorp, Inc. Common Stock
SBT
| $49M | 0.01% |
4,915,951
-26,394
| -0.5% | -$259K |
|
902
MGE Energy Inc
MGEE
$3.07B
| $49M | 0.01% |
669,885
+32,331
| +5% | +$2.22M |
|
903
Ametek
AME
$59.3B
| $48.9M | 0.01% |
537,800
+263
| +0% | +$22.5K |
|
904
Monster Beverage
MNST
$90.1B
| $48.7M | 0.01% |
3,049,632
+1,736
| +0.1% | +$26.2K |
|
905
CAE Inc. Common Shares
CAE
$8.9B
| $48.6M | 0.01% |
1,805,013
-6,874
| -0.4% | -$168K |
|
906
Factset
FDS
$9.89B
| $48.6M | 0.01% |
169,559
-3,759
| -2% | -$1.04M |
|
907
Snap
SNAP
$8.79B
| $48.4M | 0.01% |
3,384,158
+3,023,183
| +838% | +$37M |
|
|
CMD
908
DELISTED
Cantel Medical Corporation
CMD
| $48.3M | 0.01% |
598,723
-2,901
| -0.5% | -$204K |
|
909
i3 Verticals
IIIV
$323M
| $48.2M | 0.01% |
1,637,584
-124,576
| -7% | -$3.08M |
|
910
Enbridge
ENB
$112B
| $47.8M | 0.01% |
1,324,959
-143,441
| -10% | -$5.22M |
|
|
EVOP
911
DELISTED
EVO Payments, Inc. Class A Common Stock
EVOP
| $47.4M | 0.01% |
1,504,268
+93,599
| +7% | +$2.73M |
|
912
Elastic
ESTC
$8.02B
| $47.4M | 0.01% |
634,715
+491,848
| +344% | +$40.1M |
|
913
Unifirst Corp
UNF
$5.24B
| $47.3M | 0.01% |
250,955
+30,000
| +14% | +$4.85M |
|
914
Nektar Therapeutics
NKTR
$2.57B
| $47.1M | 0.01% |
88,235
-4,863
| -5% | -$2.44M |
|
915
Perdoceo Education
PRDO
$1.96B
| $47M | 0.01% |
2,462,056
-766,719
| -24% | -$14.1M |
|
916
Reliance Steel & Aluminium
RS
$21.8B
| $46.8M | 0.01% |
495,129
-90,364
| -15% | -$8.09M |
|
917
Schneider National
SNDR
$6.27B
| $46.3M | 0.01% |
2,539,359
-27,151
| -1% | -$526K |
|
|
HAYN
918
DELISTED
Haynes International, Inc.
HAYN
| $46.3M | 0.01% |
1,455,676
+3,430
| +0.2% | +$110K |
|
919
M&T Bank
MTB
$36.6B
| $45.7M | 0.01% |
268,629
+2,017
| +0.8% | +$334K |
|
920
Frontdoor
FTDR
$5.89B
| $45.6M | 0.01% |
1,048,145
-8,714,397
| -89% | -$335M |
|
921
Carter's
CRI
$1.43B
| $45.6M | 0.01% |
467,087
+129,941
| +39% | +$12.7M |
|
|
TWTR
922
DELISTED
Twitter, Inc.
TWTR
| $45.2M | 0.01% |
1,293,828
+2,720
| +0.2% | +$99.8K |
|
923
Gaotu Techedu
GOTU
$410M
| $45M | 0.01% |
+4,172,900
| New | +$40.3M |
|
924
Realty Income
O
$59.2B
| $45M | 0.01% |
672,903
+93,191
| +16% | +$6.36M |
|
925
Essential Utilities
WTRG
$11.3B
| $44.9M | 0.01% |
1,084,411
+996,901
| +1,139% | +$38.8M |
|
Similar funds
T. Rowe Price Associates's Q2 2019 Portfolio in Review
As of Q2 2019, T. Rowe Price Associates held 2,600 positions worth $712B, up 4.7% from $680B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
T. Rowe Price Associates's Q2 2019 filing shows 72 new, 1,394 increased, 949 reduced and 59 closed positions. Its largest new stake was Alcon: 36,020,796 shares worth $2.23B. The largest sale was UnitedHealth, an estimated $2.27B.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Healthcare and Financials.
- T. Rowe Price Associates's largest Q2 2019 buy was Alcon: 36,020,796 shares worth $2.23B.
- T. Rowe Price Associates added most to Linde in Q2 2019, an estimated $1.34B increase.
- T. Rowe Price Associates's biggest Q2 2019 reduction was UnitedHealth, cutting an estimated $2.27B.
- T. Rowe Price Associates fully exited Ultimate Software Group Inc in Q2 2019, selling an estimated $609M.
- T. Rowe Price Associates's ten largest holdings make up 21% of its $712B portfolio in Q2 2019.
- T. Rowe Price Associates opened 72 new positions and closed 59 in Q2 2019.
- T. Rowe Price Associates's portfolio value rose 4.7% quarter-over-quarter to $712B.
Based on T. Rowe Price Associates's 13F filing for Q2 2019, filed 15 Aug 2019.